FDA OKs First Treatment for Pediatric Lupus

Belimumab (Benlysta) intravenous infusion, already approved in adults, may now be used in children aged 5 years and older with active SLE.
FDA Approvals

Source link

Related posts

Generation of two induced pluripotent stem cells lines from a Mucopolysaccharydosis IIIB (MPSIIIB) patient.


Clinical validity of novel postural stabilization experimental indices based on hyperbolic transformation.


FGFR1 actionable mutations, molecular specificities, and outcome of adult midline gliomas


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy